US Markets

Trump says may or may not approve stricter FDA guidelines for COVID-19 vaccine

Credit: REUTERS/ANDREW KELLY

U.S. President Donald Trump said on Wednesday he may or may not approve potentially new, more stringent standards for an emergency authorization of a COVID-19 vaccine by the U.S. Food and Drug Administration, saying such a move would appear political.

WASHINGTON, Sept 23 (Reuters) - U.S. President Donald Trump said on Wednesday he may or may not approve potentially new, more stringent standards for an emergency authorization of a COVID-19 vaccine by the U.S. Food and Drug Administration, saying such a move would appear political.

The Washington Post reported on Tuesday the FDA would issue the guidance to boost transparency and public trust as health experts have become increasingly concerned the Trump administration might be interfering in the approval process.

"That has to be approved by the White House. We may or may not approve it," Trump told a White House news conference.

"That sounds like a political move."

(Reporting by Jeff Mason and Eric Beech, writing by Phil Stewart, editing by Chris Reese)

((phillip.stewart@thomsonreuters.com; 1-202-898-8398; Reuters Messaging: phillip.stewart.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More